doi: 10.1016/j.fct.2017.05.006
19 The mean change in body weight from baseline to week 68 was 14.9% in the semaglutide group compared with 2.4% with placebo, for an estimated treatment difference of 12.4 percentage points (95% confidence interval [CI], 13.4 to 11.5
[DOI] [PubMed] [Google Scholar] 19.Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S
Exendin-4 differentially modulates essential functions of human dermal fibroblasts under normoglycemic and hyperglycemic conditions
143 The safety profile of tirzepatide is similar to other drugs in its class, providing an effective new treatment option for patients with T2DM and obesity
Foaming can make it difficult to accurately measure and administer the dose, potentially leading to incorrect dosing and reduced efficacy